HUTCHMED DRC Filter Stocks by Fundamentals
| HCM Stock | USD 13.31 -0.12 -0.89% |
| = | null |
Did You Try This?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Important Fundamentals
| Return On Equity TTM | 0.45 | |||
| Return On Asset TTM | -0.0162 | |||
| Profit Margin TTM | 0.83 | |||
| Operating Margin TTM | -0.13 | |||
| Current Valuation | 997.87 M | |||
| Shares Outstanding | 171.95 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 3.06 % | |||
| Number Of Shares Shorted | 306.83 K | |||
| Price To Earnings TTM | 335.94 X | |||
| Price To Book TTM | 1.83 X | |||
| Price To Sales TTM | 4.14 X | |||
| Revenue TTM | 549.96 M | |||
| Gross Profit TTM | 63.87 M | |||
| EBITDA TTM | -41.38 M | |||
| Net Income TTM | 458.12 M | |||
| Cash And Equivalents TTM | 829.71 M | |||
| Cash Per Share TTM | 4.91 X | |||
| Total Debt TTM | 97.89 M | |||
| Current Ratio TTM | 3.18 X | |||
| Book Value Per Share TTM | 7.20 X | |||
| Cash Flow From Operations TTM | -64.83 M | |||
| Short Ratio TTM | 8.94 X | |||
| Earnings Per Share | 2.65 X | |||
| Target Price | 22.85 | |||
| Number Of Employees | 1.8 K | |||
| Trailing Beta | 0.38 | |||
| Market Capitalization TTM | 2.27 B | |||
| Total Asset TTM | 1.75 B | |||
| Retained Earnings TTM | -378.64 M | |||
| Working Capital TTM | 1.25 B | |||
| Current Asset TTM | 187.47 M | |||
| Current Liabilities TTM | 96.7 M | |||
| Net Asset | 1.75 B |
Financial Metrics, Fundamentals & Methodology
The financial architecture of HUTCHMED DRC shows how effectively the business turns scale into retained value. Cash-flow trends help test whether reported earnings are being backed by real operating performance. In recent filings, HUTCHMED DRC reported revenue of 549.96 million, positive EPS of 2.65, negative operating margin of 13.16% as of the latest reporting period.
HUTCHMED DRC data is compiled from periodic company reporting and market reference feeds and standardized for comparability. Financial statement fields are presented under issuer-reported GAAP or IFRS accounting conventions.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board